Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KK Therapeutics ApS
APS
Dissolved
CVR 40378111
Amagerbrogade 18, 1. th
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2019
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK -30K
EBITDA margin
100.0%
Equity ratio
73.4%
Financial strength
Net profit 2019
DKK -33K
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2019
Key figures
Annual report 2019
Revenue
DKK -30K
—
EBITDA
DKK -30K
—
Net profit
DKK -33K
—
Total assets
DKK 23K
—
Equity
DKK 17K
—
Employees
—
—
Company information
Legal name
KK Therapeutics ApS
CVR number
40378111
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
21. marts 2019
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Contact
Address
Amagerbrogade 18, 1. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2019
Income statement
DKK thousands
Item
2019
Revenue
-30
Staff expenses
-0
EBITDA
-30
Depreciation & amort.
-0
EBIT
-30
Net financials
-3
Profit before tax
-33
Tax
-0
Net profit
-33
Balance sheet
DKK thousands
Item
2019
Total assets
23
Equity
17
Long-term debt
0
Short-term debt
6
Total debt
6
Financial ratios
5-year trend
EBITDA margin
-3000000.0%
This company
15.8%
Market median
-18987442% vs market
2019
2019
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
2019
2019
Return on equity
-190.5%
This company
18.4%
Market median
-1135% vs market
2019
2019
Net profit margin
-3279000.0%
This company
8.1%
Market median
-40481581% vs market
2019
2019
Asset turnover
-1.28×
This company
1.12×
Market median
-214% vs market
2019
2019
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
2019
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-03-21 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Karl Agger
Individual
50.0%
50.0%
2019
Kristian Helin
Individual
50.0%
50.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of KK Therapeutics ApS also hold positions in
0
other companies.
Person
Role here
Other companies